Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer’s Disease

被引:0
|
作者
Heidi Taipale
Hanna Vuorikari
Antti Tanskanen
Marjaana Koponen
Jari Tiihonen
Raimo Kettunen
Sirpa Hartikainen
机构
[1] University of Eastern Finland,Kuopio Research Centre of Geriatric Care
[2] University of Eastern Finland,School of Pharmacy
[3] University of Eastern Finland,Research Centre for Comparative Effectiveness and Patient Safety (RECEPS)
[4] Karolinska Institutet,Department of Clinical Neuroscience
[5] National Institute for Health and Welfare,Department of Forensic Psychiatry, Niuvanniemi Hospital
[6] University of Eastern Finland,School of Medicine
[7] University of Eastern Finland,undefined
来源
Drugs & Aging | 2015年 / 32卷
关键词
Warfarin; International Normalise Ratio; Tramadol; Bleeding Risk; Antithrombotic Drug;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:937 / 945
页数:8
相关论文
共 4 条
  • [1] Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: A prospective observational study
    Teklay G.
    Shiferaw N.
    Legesse B.
    Bekele M.L.
    Thrombosis Journal, 12 (1)
  • [2] Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection
    Martins, Maria A. P.
    Ribeiro, Daniel D.
    Nobre, Vandack A.
    Pereira, Fabiana R.
    Cesar, Cibele C.
    Rocha, Manoel O. C.
    Ribeiro, Antonio L. P.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 919 - 928
  • [3] Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy
    Selak, Vanessa
    Kerr, Andrew
    Poppe, Katrina
    Wu, Billy
    Harwood, Matire
    Grey, Corina
    Jackson, Rod
    Wells, Sue
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (24): : 2507 - 2520
  • [4] Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection
    Maria A. P. Martins
    Daniel D. Ribeiro
    Vandack A. Nobre
    Fabiana R. Pereira
    Cibele C. César
    Manoel O. C. Rocha
    Antonio L. P. Ribeiro
    European Journal of Clinical Pharmacology, 2013, 69 : 919 - 928